Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2021-05-20 Capital/Financing Update
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Expiry of Performance Options 1 page 83.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release titled 'Expiry of Performance Options' dated 21 May 2021. It details the forfeiture of performance options due to unmet revenue hurdles. The content focuses on a specific capital structure event related to performance options and does not contain financial statements or comprehensive financial data. It is an announcement about changes in the company's capital instruments (performance options), which aligns with capital or financing updates. The document length is short (2188 characters), and it is not a report or a certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-05-20 English
Nanoveu to Pursue US Sales with EPA Approval 3 pages 130.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX release dated 6 May 2021 from Nanoveu Limited announcing a memorandum of understanding (MoU) for sourcing active ingredients for their Nanoshield product from a US-based supplier with EPA approval. The content focuses on business development, regulatory approval, and market expansion in the US. It is a corporate announcement about a commercial agreement and regulatory status, not a financial report, earnings release, or management discussion. The document is not a report itself but an announcement of a business update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and corporate updates that do not fit other specific categories.
2021-05-05 English
Notice Required Under ASX Listing Rule 3.13.1 2 pages 102.6KB
AGM Information Classification · 95% confidence The document is an ASX release dated 30 April 2021 from Nanoveu Limited. It announces the intention to hold the company's Annual General Meeting (AGM) for 2021 on or after 18 June 2021. It discusses the re-election of directors as an item of business and provides details about the nomination deadline for director elections. The document also references regulatory guidance from ASIC regarding the postponement of AGMs due to COVID-19. There are no financial statements, detailed financial data, or management discussion of results. The document is a notice about the upcoming AGM and related procedural information, not the AGM materials themselves or the full annual report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including notices and announcements related to the AGM.
2021-04-29 English
Appendix 4C - quarterly 13 pages 2.0MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report and Appendix 4C For the Quarter Ended 31 March 2021' and is an ASX release. It contains detailed operational updates, distribution agreements, product launches, and some financial information related to cash flow for the quarter. The document is about quarterly activities and includes substantive financial and operational data for a period shorter than a full fiscal year. It is not merely an announcement of a report but contains actual data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-04-28 English
Exclusive Distribution Agreement for Indian Market 3 pages 145.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing an exclusive distribution agreement for the Indian market by Nanoveu Limited. It details the terms of the agreement, the parties involved, and the strategic importance of the deal. There are no financial statements, quarterly or annual results, nor any regulatory certifications or voting results. The content is focused on a business update related to capital and sales activities, specifically a distribution agreement and prepaid purchase orders. This fits the category of Capital/Financing Update (CAP), as it relates to company fundraising, financing activities, or capital structure changes through commercial agreements. The document length is over 7,000 characters and contains substantive information about the agreement, not just an announcement of a report or a brief summary. Therefore, the appropriate classification is CAP with high confidence.
2021-04-26 English
Appendix 2A 15 pages 225.4KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of +securities' and references ASX Listing Rules. It is an application form for the quotation of securities on the Australian Securities Exchange (ASX). The content includes details about the entity, the type of securities to be quoted, dates of previous announcements (Appendix 3B), and other regulatory compliance information related to securities issuance and quotation. This is a regulatory announcement related to capital markets activity, specifically the application for quotation of securities, which aligns with capital/financing updates. It is not a financial report, earnings release, or management report. It is not a proxy, voting, or governance document. The document is substantive and not a mere announcement of a report. Therefore, the best fitting category is Capital/Financing Update (CAP).
2021-04-05 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.